Abstract:Venomous agent X (VX) is an organophosphate acetylcholinesterase (AChE) inhibitor, and although it is one of the most toxic AChE inhibitors known, the extent of metabolism in humans is not currently well understood. The known metabolism in humans is limited to the metabolite identification from a single victim of the Osaka poisoning in 1994, which allowed for the identification of several metabolic products. VX has been reported to be metabolized in vitro by paraoxonase-1 and phosphotriesterase, although their binding constants are many orders of magnitude above the LD50, suggesting limited physiologic relevance. Using incubation with human liver microsomes (HLMs), we have now characterized the metabolism of VX and the formation of multiple metabolites as well as identified a Food and Drug Administration-approved drug [ethylenediaminetetraacetic acid (EDTA)] that enhances the metabolic rate. HLM incubation alone shows a pronounced increase in the metabolism of VX compared with buffer, suggesting that cytochrome P450-mediated metabolism of VX is occurring. We identified a biphasic decay with two distinct rates of metabolism. The enhancement of VX metabolism in multiple buffers was assessed to attempt to mitigate the effect of hydrolysis rates. The formation of VX metabolites was shown to be shifted with HLMs, suggesting a pathway enhancement over simple hydrolysis. Additionally, our investigation of hydrolysis rates in various common buffers used in biologic assays discovered dramatic differences in VX stability. The new human in vitro VX metabolic data reported points to a potential in vivo treatment strategy (EDTA) for rescue in individuals that are poisoned though enhancement of metabolism alongside existing treatments. SIGNIFICANCE STATEMENT: Venomous agent X (VX) is a potent acetylcholinesterase inhibitor and chemical weapon. To date, we do not possess a clear understanding of its metabolism in humans that would assist us in treating those exposed to it. This study now describes the human liver microsomal metabolism of VX and identifies ethylenediaminetetraacetic acid, which appears to enhance the rate of metabolism. This may provide a potential treatment option for human VX poisoning.

Oxidative detoxification of nerve agent VX simulant by polyoxoniobate: Experimental and theoretical insights

Detoxification of V‐nerve agents assisted by a microperoxidase: new pathway revealed by the use of a relevant VX simulant

Revealing nitrogenous VX metabolites and the whole-molecule VX metabolism in the urine of guinea pigs

In Vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes

Acid-promoted synthesis of defected UiO-66-NH2 for rapid detoxification of chemical warfare agent simulant

A MOF-doped molecularly imprinted polymer/MOF hybrid gel incorporating with pH-buffering sodium acrylate for practical detoxification of organophosphorus nerve agents

Efficient synthesis of MOF-808 nanoparticles for rapid hydrolysis of V-series nerve agent simulant

Detoxification of the Toxic Sulfur Mustard Simulant by a Supramolecular Antidote in Vitro and in Vivo

Synergistic Elimination of NOx and Chlorinated Organics over VOx/TiO2 Catalysts: A Combined Experimental and DFT Study for Exploring Vanadate Domain Effect.

Selective detoxification of a sulfur mustard simulant in air by a methylene blue functionalized metal-organic frameworks

Asymmetric biodegradation of the nerve agents Sarin and VX by human dUTPase: chemometrics, molecular docking and hybrid QM/MM calculations

Detoxification of Chemical Warfare Agents by a Zr‐Based MOF with High Recycling Ability at Physiological pH

Hollow-Architected Heteroatom-Doped Carbon-Supported Nanoscale Cu/Co as an Enhanced Magnetic Activator for Oxone to Degrade Toxicants in Water

A two-in-one sensing solvent for green extraction and analysis of N-oxide based explosives

Exclusively Generating Superoxide Radical by Porous Aromatic Frameworks for Fast Photocatalytic Decontamination of Mustard Gas Simulant in Room Air

MOF-Polymer Mixed Matrix Membranes as Chemical Protective Layers for Solid-Phase Detoxification of Toxic Organophosphates

Enzyme Nanoreactor for In Vivo Detoxification of Organophosphates

Post-VX exposure treatment of rats with engineered phosphotriesterases

Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers

A MOFs/MIPs@GAs Ternary Composite Catalytic System with Graphene Oxide Aerogels as the Multifunctional Skeleton for High-Efficiency Detoxification of Organophosphate Nerve Agents in Pure Water

Supramolecular detoxification of nitrogen mustard via host-guest encapsulation by carboxylatopillar[5]arene